Rephonic
Artwork for Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers
Immunotherapy
Non-Small Cell Lung Cancer
Chemotherapy
Small Cell Lung Cancer
Renal Cell Carcinoma
Neuroendocrine Tumors
Diffuse Large B-Cell Lymphoma
Pancreatic Cancer
Acute Myeloid Leukemia
Bladder Cancer
Multiple Myeloma
Breast Cancer
Clinical Trials
Her2-Positive Breast Cancer
Nivolumab
Chronic Myeloid Leukemia
Prostate Cancer
FDA Approval
Lung Cancer
Pembrolizumab

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and ... more

PublishesDailyEpisodes302Founded4 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for Oncology Brothers: Practice-Changing Cancer Discussions

Latest Episodes

Join us as we discussed the practice changing/informing studies presented at ESMO 2026. In this episode, we welcomed Dr. Javier CortĂŠs, from Spain to discuss 4 key studies that are shaping the future of breast cancer treatment.

Episode Highlights:

more

Welcome to the Oncology Brothers podcast! In this episode, we dived deep into the complex world of neuroendocrine tumors (NETs) with renowned specialist Dr. Pamela Kunz, from Yale School of Medicine.

Join us as we explore:

• The heterogeneous natur... more

In this segment of the treatment algorithms, we focused on rectal cancer treatment landscape with Dr. Nina Sanford, a radiation oncologist, and Dr. Madhu Eluri, MD, a medical oncologist.

In this episode, we discussed:

• The recent approval of dosta... more

In this episode of the Oncology Brothers podcast, we dived deep into the world of uncommon EGFR mutations in non-small cell lung cancer (NSCLC). Joined by Dr. Susan Scott, a thoracic medical oncologist from the Johns Hopkins School of Medicine, as we... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
OncLiveÂŽ On Air
OncLiveÂŽ On AirOncLiveÂŽ On Air
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Manish Shah
GI medical oncologist
Episode: ESMO 2026 GI Cancer Highlights: HERIZON-GEA-01, CLARITY-GASTRIC01, AZUR1, CHECKMATE 8HW, HARMONi-GI1
Eric Van Cutsem
GI medical oncologist
Episode: ESMO 2026 GI Cancer Highlights: HERIZON-GEA-01, CLARITY-GASTRIC01, AZUR1, CHECKMATE 8HW, HARMONi-GI1
Ari Rosenberg
Oncologist at the University of Chicago
University of Chicago
Episode: ESMO 2026 Head & Neck Melanoma Highlights OrigAMI-4, INTerpath-001, STARBOARD
Sapna Patel
Melanoma oncologist at the University of Colorado
University of Colorado
Episode: ESMO 2026 Head & Neck Melanoma Highlights OrigAMI-4, INTerpath-001, STARBOARD
Sumanta Pal
Genitourinary medical oncologist at City of Hope
City of Hope
Episode: RCC Management in Localized & Metastatic Disease with Dr. Monty Pal - Rapid-Fire Rounds
Shilpa Gupta
Medical oncologist at Cleveland Clinic
Cleveland Clinic
Episode: ESMO 2026 GU Highlights VOLGA, DASL-HiCAP, PROTEUS, KEYNOTE-564, LITESPARK-011
Ashish Kamat
Urologist at MD Anderson
MD Anderson
Episode: ESMO 2026 GU Highlights VOLGA, DASL-HiCAP, PROTEUS, KEYNOTE-564, LITESPARK-011
Rafael Fonseca
Multiple myeloma specialist at Mayo Clinic.
Mayo Clinic
Episode: Multiple Myeloma CAR-T Management - Partners in Practice
Beth Faiman
Nurse practitioner specializing in myeloma.
Episode: Multiple Myeloma CAR-T Management - Partners in Practice

Hosts

Rahul Gosain
Co-host of the Oncology Brothers Podcast; physician specializing in oncology with clinical practice in community setting
Rohit Gosain
Co-host of the Oncology Brothers Podcast; physician specializing in oncology with clinical practice in community setting

Reviews

4.7 out of 5 stars from 131 ratings
  • Go to Resource for Oncology Updates

    The Oncology brothers do an excellent job of bridging the gap between academia and community oncology. They provide timely oncology updates and discuss the clinical impact, diving into practice changing discussion with guest experts. Hands down my go to resource for oncology updates 🙌

    Apple Podcasts
    5
    Hemoncdoc_
    United States2 months ago
  • Oncology Brothers: Setting a New Standard in Medical Education

    The Oncology Brothers have become a go-to in my week. They take the constant firehose of oncology data—new FDA approvals, shifting algorithms, and “practice-changing” abstracts—and turn it into something practical I can actually use in clinic the next day. The conversations feel like sitting down with smart colleagues who care about evidence, clarity, and real-world decision making, not just reciting trial slides. It’s exactly the kind of thoughtful, high-yield education our field needs more of.... more

    Apple Podcasts
    5
    DD1384
    United States10 months ago
  • Excellent Resource

    I regularly listen to this podcast and find it an excellent reference for oncology practice. The speakers consistently provide valuable insights that are both practical and informative. It's a great resource for staying updated and enhancing clinical knowledge.

    Apple Podcasts
    5
    RHJ, MD
    United Statesa year ago
  • Insightful, relatable, and essential for anyone in the oncology community

    The Oncology Brothers consistently deliver relevant, easy-to-digest insights on complex data and evolving treatment landscapes. Their ability to break down key updates—especially for those who can't attend every conference—is incredibly valuable. A must-listen for anyone in oncology looking to stay current and connected to the community.

    Apple Podcasts
    5
    OncoScriber
    United Statesa year ago
  • Stage IV CRC

    Thank you so much for putting this together! Love the updates of ongoing research! I am the primary caretaker for my 79 year old dad who was diagnosed 6/24 with stage IV CRC MSS KRAS G13D TMB-H, so love your GI updates from ASCO ‘25 and subcutaneous nivo, which we are considering. Hope you do more like bot/bal and neodadjuvant single cycle pembro. Thanks for taking the time to do this!!

    Apple Podcasts
    5
    mama4travel
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Audience notes the hosts' clear communication and evidence-based approach
Community oncologists appreciate real-world sequencing and toxicity management guidance
Physicians praise practical, high-yield education that translates to day-to-day practice
Listeners value concise updates on rapidly evolving oncology data

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

RCC Management in Localized & Metastatic Disease with Dr. Monty Pal - Rapid-Fire Rounds
Q: What's your go-to between IO-IO and IO-TKI, and how are you picking one among the other?
Pal considers all four main regimens reasonable. For disease requiring an immediate response, such as threatening bone lesions or substantial visceral disease, he favors an IO-TKI combination, often cabozantinib plus nivolumab. For patients with more time to respond, he may use nivolumab plus ipilimumab, while considering its higher primary progression rate.
RCC Management in Localized & Metastatic Disease with Dr. Monty Pal - Rapid-Fire Rounds
Q: For a high-risk patient treated locally who cannot have surgery, would you favor adjuvant pembrolizumab or pembrolizumab plus belzutifan?
Pal bases the choice on anticipated disease stage and risk. He may offer pembrolizumab, or consider adding belzutifan for higher-risk disease, while saying he uses the combination less often pending overall survival evidence.
ESMO 2026 GU Highlights VOLGA, DASL-HiCAP, PROTEUS, KEYNOTE-564, LITESPARK-011
Q: Who is the right patient for a POTOMAC-based approach in the clinic?
Ashish Kamat identifies very-high-risk patients, particularly those with multifocal or deep T1 disease, as potential candidates for durvalumab plus BCG. He says the discussion should weigh recurrence benefit and added toxicity, since progression benefit has not been shown.
ESMO 2026 GU Highlights VOLGA, DASL-HiCAP, PROTEUS, KEYNOTE-564, LITESPARK-011
Q: Could the VOLGA approach become a new standard of care for resectable muscle-invasive bladder cancer?
Ashish Kamat says it may encourage more urologists to refer patients for neoadjuvant treatment because of its efficacy and toxicity profile, but he is unsure it will replace the EV-pembrolizumab approach. Shilpa Gupta emphasizes following the trial regimen rather than mixing treatments.
ESMO 2026 Head & Neck Melanoma Highlights OrigAMI-4, INTerpath-001, STARBOARD
Q: Can you touch on INTerpath-001 study from ESMO and what that means for us today?
Patel explains that personalized mRNA vaccine plus pembrolizumab improved recurrence-free survival compared with pembrolizumab alone in the adjuvant setting, while noting injection effects and logistical challenges around tissue collection and manufacturing.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

A concise, practitioner-focused show that translates cutting-edge oncology data into practical guidance for community clinicians. Episodes frequently feature hematology/oncology specialists from top academic centers who discuss treatment sequencing, real-world toxicity management, and emerging therapies across cancers like multiple myeloma, DLBCL, AML, and solid tumors such as pancreatic and breast cancer. Dialogues center on translating conference highlights, trial data, and evolving guidelines into actionable decision-making for frontline and relapsed settings, with an emphasis on patient quality of life and team-based care. Noteworthy are the frequent cross-center collaborations, deep dives into sequencing decisions, and a clear aim to b... more

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Two Onc Docs
2. Oncology Today with Dr Neil Love
3. Research To Practice | Oncology Videos
4. OncLiveÂŽ On Air
5. ASCO Daily News

How many episodes of this podcast are there?

this podcast launched 4 years ago and published 302 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Manish Shah
2. Eric Van Cutsem
3. Ari Rosenberg
4. Sapna Patel
5. Sumanta Pal
6. Shilpa Gupta
7. Ashish Kamat
8. Rafael Fonseca

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days